Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs

Clinical trial NCT07384013 · RECRUITING

Trial details

NCT number: NCT07384013
Sponsor: Rambam Health Care Campus
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Oncologic Diseases Coagulation Defect Pain Management

Start date: 2025-11-01
Primary completion: 2027-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.